Chantel Jacobs
Family Medicine · St Petersburg, FLNPI 1821476458
Payments from drug & device makers
Across 213 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$621
- Lilly USA, LLC$476
- Takeda Pharmaceuticals U.S.A., Inc.$439
- AstraZeneca$392
- GSK$270
- Amarin Pharma, Inc.$236
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,898100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $621 |
| Lilly USA, LLC | 30 | $476 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $439 |
| AstraZeneca | 24 | $392 |
| GSK | 14 | $270 |
| Amarin Pharma, Inc. | 12 | $236 |
| Amgen | 13 | $222 |
| Boehringer Ingelheim | 10 | $222 |
| AbbVie(2 entities) | 10 | $194 |
| Pfizer | 9 | $184 |
| Intuitive Surgical | 1 | $99 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $95 |
| Medtronic(2 entities) | 2 | $87 |
| Biohaven Pharmaceuticals, Inc. | 4 | $77 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $76 |
| Radius Health, Inc. | 2 | $36 |
| Eisai Inc. | 2 | $34 |
| Bausch Health US, LLC | 2 | $33 |
| Phadia US Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $16 |
| IBSA Pharma Inc. | 1 | $16 |
How this compares
$3,898 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 16 | $11,779 |
| Gabapentin | 26 | $513 |
| Levothyroxine Sodium | 27 | $301 |
| Atorvastatin Calcium | 24 | $223 |
| ClopidogrelClopidogrel Bisulfate | 14 | $169 |
| Omeprazole | 18 | $135 |
| Lisinopril | 15 | $119 |
| Amlodipine Besylate | 21 | $116 |
| Losartan Potassium | 19 | $102 |
| Spironolactone | 11 | $80 |
| Furosemide | 12 | $70 |
| Pravastatin Sodium | 18 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $222 | $11,77916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.
Other family medicine in St Petersburg
- Gigi LefebvreSt Petersburg$9.2M
- Roxana StoiciSt Petersburg$9.1M
- Linda MurraySt Petersburg$4.1M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.